Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ken Frazier
Biotech
Eikon drops hints at early pipeline, plans for $660M+ reservoir
After raising more than $660 million, Eikon Therapeutics' future plans are coming into clearer view, with an oncology pipeline underway.
Max Bayer
Jun 30, 2022 2:20pm
John Mascola moves on from NIAID's R&D hub—Chutes and Ladders
Apr 1, 2022 9:30am
Reuniting the band: Former Merck CEO follows colleagues to Eikon
Mar 31, 2022 10:13am